Status:
UNKNOWN
Conduct of Nasal High Flow Oxygen in Acute Respiratory Failure
Lead Sponsor:
Hôpital Louis Mourier
Conditions:
Acute Respiratory Failure With Hypoxia
Hypoxemia
Eligibility:
All Genders
18+ years
Brief Summary
Although many studies have investigated the clinical benefits of nasal high flow during acute hypoxemic respiratory failure, there is no data (and even less so recommendations) on how to best conduct ...
Detailed Description
Nasal high flow oxygen therapy is increasingly used as a first-line treatment for hypoxemic acute respiratory failure, because of its remarkable tolerance (in comparison with NIV) and its physiologica...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients aged 18 or older
- admitted to the intensive care unit (ICU) or to the intermediate care for acute hypoxemic respiratory failure (whatever the cause)
- treated with nasal high flow oxygen therapy
- with a minimal FiO2 of FiO2≥50% and a gas flow ≥40 L/min
- anticipated duration of nasal high flow therapy greater or equal to 24 hours
- Non-inclusion Criteria:
- prophylactic, post-extubation nasal high flow therapy
- palliative nasal high flow therapy (do-not-resuscitate order)
- Exclusion criteria
- \- nasal high flow therapy administered for less than 24 hours
Exclusion
Key Trial Info
Start Date :
July 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03311087
Start Date
July 9 2018
End Date
November 1 2018
Last Update
July 20 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Réanimation Médico-Chirurgicale
Colombes, France, 92700
2
Service de Réanimation Médicale
Dijon, France
3
Service de Réanimation Médicale
Grenoble, France
4
Service de Réanimation
Longjumeau, France